학술논문

Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis
Document Type
Article
Source
In: Arthritis and Rheumatology. (Arthritis and Rheumatology, September 2023, 75(9):1608-1618)
Subject
Language
English
ISSN
23265205
23265191